This workshop – which is free to attend and open to all ARM members – will provide a forum for industry experts to present and discuss current technological advancements in cryogenic management, regulatory requirements and best practices for processes in the support of regenerative medicine commercialization.
Bringing together key influencers from pharma and biotech companies across the world, the Cell Therapy Manufacturing Asia Congress will provide you with the latest advice for driving manufacturing and commercialisation through direct access to innovative research transforming cell manufacturing.
Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
The event is meant to provide a “speaker’s corner” for those who seek to engage partnerships with Japanese companies with respect to the development of their own product pipelines and/or technology seeds in Japan.
Bringing together 300+ leaders and key influencers from pharma and biotech companies on 6 – 7 December 2017 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy Congress will provide you with the latest advice for driving manufacturing and commercialisation through direct access to transforming innovative research to prosperous cell & gene manufacturing.
The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships.
The AABB Cellular Therapies Certificate Program is now available. The 12-module program is produced by a panel of expert faculty members in partnership with The George Washington University.
RARE Partnering 2017 is a forum to catalyze partnering and collaboration opportunities between innovative researchers, research institutions and companies with an interest in rare disease.
